Indivior Archives -

Indivior has paid out $300 million to resolve civil claims from US states after it was last year

Indivior pays $300m to settle Suboxone marketing allegations

https://pharmaphorum.com/news/indivior-pays-300m-to-settle-suboxone-marketing-allegations/

UK drugmaker Indivior looks finally to have put years of uncertainty over its exposure to opioid litigation in

After final $600M opioid settlement, Indivior looks to the future

https://pharmaphorum.com/news/after-final-600m-opioid-settlement-indivior-looks-to-the-future/

The resignation of Indivior chief executive Shaun Thaxter this week was swiftly followed by a guilty plea –

Indivior ex-CEO could face jail time after opioid conviction

https://pharmaphorum.com/news/indivior-ex-ceo-could-face-jail-time-after-opioid-conviction/

A US district court has ruled that the FDA must reconsider its decision to reject a long-lasting opioid

FDA to reconsider Braeburn’s opioid addiction drug after court ruling

https://pharmaphorum.com/news/fda-to-reconsider-braeburns-opioid-addiction-drug-after-court-ruling/

Shares in UK drugmaker Indivior have gone into freefall after it was charged by the US Department of

Indivior stung by fraud charges over US marketing

https://pharmaphorum.com/news/indivior-stung-by-fraud-charges-over-us-marketing/

Pharma companies always need to know they can get the right information to the right people at the

Ensuring delivery of healthcare professional education

https://pharmaphorum.com/debates-insight-sales-marketing/ensuring-delivery-of-healthcare-professional-education/

Indivior has suffered a critical defeat in the US courts for opioid addiction product Suboxone Film, opening the

Indivior hit hard as generic Suboxone defence crumbles

https://pharmaphorum.com/news/indivior-hit-hard-as-generic-suboxone-defence-crumbles/

Regulators authorities in the US have approved Indivior’s long-acting injectable treatment for adults with schizophrenia. Perseris (risperidone) won

Indivior’s once-monthly schizophrenia injection gets US green light

https://pharmaphorum.com/news/indivior-schizophrenia-perseris-fda/

Indivior